-
1 Comment
Eastwood Bio-Medical Canada Inc is currently in a long term downtrend where the price is trading 10.6% below its 200 day moving average.
From a valuation standpoint, the stock is 82.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 182.2.
Eastwood Bio-Medical Canada Inc's total revenue rose by 48.4% to $203K since the same quarter in the previous year.
Its net income has dropped by 13.2% to $-276K since the same quarter in the previous year.
Finally, its free cash flow grew by 81.4% to $-29K since the same quarter in the previous year.
Based on the above factors, Eastwood Bio-Medical Canada Inc gets an overall score of 3/5.
| Exchange | V |
|---|---|
| CurrencyCode | CAD |
| ISIN | CA27783W1059 |
| Sector | Consumer Defensive |
| Industry | Food Distribution |
| Market Cap | 30M |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | -0.22 |
| Dividend Yield | None |
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. The company's products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EBM.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
